Home // Company // Sustainability // Performance // EPS Expansion EPS Expansion And combined efforts to execute our strategy have worked.  2018 marked the ninth consecutive year of adjusted EPS expansion at Avient, as we delivered $2.43 per share. 

Homepage // News Center // PolyOne Showcases Expansive Fiber Colorants & Additives Portfolio at ITMA 2019

Homepage // News Center // Medtec China 2024: Avient Announces Healthcare TPU Manufacturing Expansion Avient Announces Healthcare TPU Manufacturing Expansion and Showcases Specialty and Sustainable Materials for Healthcare at Medtec China 2024

Avient Announces Expansion of NEUSoft™ TPU Manufacturing to China at Medtec China 2024, Enhancing Service for APAC Customers Avient Announces Healthcare TPU Manufacturing Expansion and Showcases Specialty and Sustainable Materials for Healthcare at Medtec China 2024 To dow Medtec China 2024: Avient Announces Healthcare TPU Manufacturing Expansion

Homepage // News Center // Avient Announces Expansion of NEUSoft™ TPU Manufacturing to China at Medtec China 2024, Enhancing Service for APAC Customers Avient Announces Healthcare TPU Manufacturing Expansion and Showcases Specialty and Sustainable Materials for Healthcare at Medtec China 2024 To download a high-resolution image, please click here: FOR MEDIA USE ONLY

PolyOne’s expansive portfolio includes: •    ECCOH™ non-halogenated formulations featuring flame retardance with extremely low toxicity and smoke density     Maxxam™ SY, a non-halogenated polypropylene copolymer with a pre-dispersed blowing agent for up to 60 percent expansion and ease of processing

He further inspired innovation within the segment that led to expansion into specialty applications such as LED lighting and medical device housings.  Michael has overseen the significant expansion of commercial resources within the company. 

Avient Corporation today announced the expansion of its bio-based polymer solutions for medical and pharmaceutical applications PARIS – May 18, 2022 – Avient Corporation, a premier provider of specialized and sustainable material solutions and services, today announced expansion of its line of bio-based Mevopur™ medical-grade polymer solutions.

Through our strategy of intersecting high-growth markets and secular trends with our technologies to create product platforms of scale, we work to create sustainable shareholder value by driving organic revenue growth and margin expansion.